EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Gerresheimer AG's enterprise value is €4,465 Mil.
Gerresheimer AG's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 was €1,999 Mil. Therefore, Gerresheimer AG's EV-to-Revenue for today is 2.23.
The historical rank and industry rank for Gerresheimer AG's EV-to-Revenue or its related term are showing as below:
XTER:GXI'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.41 Med: 2.2 Max: 3.01
Current: 2.23
During the past 13 years, the highest EV-to-Revenue of Gerresheimer AG was 3.01. The lowest was 1.41. And the median was 2.20.
XTER:GXI's EV-to-Revenue is ranked better than 62.03% of 827
companies
in the Medical Devices & Instruments industry
Industry Median: 3.19
vs XTER:GXI: 2.23
As of today (2024-05-15), Gerresheimer AG's stock price is €100.50.
Gerresheimer AG's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 was €58.63. Therefore, Gerresheimer AG's PS Ratio for today is 1.71.
Gerresheimer AG EV-to-Revenue Historical Data
The historical data trend for Gerresheimer AG's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Gerresheimer AG's EV-to-Revenue
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's EV-to-Revenue falls into.
Gerresheimer AG's current Enterprise Value is €4,465 Mil.
Gerresheimer AG's Revenue for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,999 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG (XTER:GXI) EV-to-Revenue Explanation
Gerresheimer AG's share price for today is €100.50.
Gerresheimer AG's Revenue per Share for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €58.63.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Gerresheimer AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:GXI has been successfully added to your 